Whole Genome Sequencing
Whole Genome Sequencing is a genetic therapy with 29 clinical trials. Currently 13 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
13
trials recruiting
29
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
United States Hypophosphatasia Molecular Research Center
Uncovering the Etiologies of Non-immune Hydrops Fetalis
Implementing a National Biobank of PD With WGS and Functional Assessment of Polygenic Inheritance by iPSC Technology
Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty
Diabetes In Asians at Risk in Youth
Clinical Trials (29)
United States Hypophosphatasia Molecular Research Center
Uncovering the Etiologies of Non-immune Hydrops Fetalis
Implementing a National Biobank of PD With WGS and Functional Assessment of Polygenic Inheritance by iPSC Technology
Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty
Diabetes In Asians at Risk in Youth
Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study
National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry
Associations Between Dental Anomalies and Ocular, Cutaneous and Skin Appendages Features
"A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the European Reference Network"
Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops
Baker Gordon Syndrome Natural History Study
The Belgian Genome Resource to Resolve Rare Diseases
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models
Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Newborn Genomic Sequencing Pilot Study
Precision Medicine for Every Child With Cancer
Glioblastoma Targeted Treatment Option Maximization by WGS
Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 29